Ramanathan, R. K., Goldstein, D., Korn, R. L., Arena, F. P., Moore, M., Siena, S., . . . Von Hoff, D. D. (2016). Positron emission tomography response evaluation from a randomized phase III trial of weekly nab -paclitaxel plus gemcitabine versus gemcitabine alone for patients with metastatic adenocarcinoma of the pancreas.
Citación estilo ChicagoRamanathan, R. K., et al. Positron Emission Tomography Response Evaluation From a Randomized Phase III Trial of Weekly Nab -paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Patients With Metastatic Adenocarcinoma of the Pancreas. 2016.
Cita MLARamanathan, R. K., et al. Positron Emission Tomography Response Evaluation From a Randomized Phase III Trial of Weekly Nab -paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Patients With Metastatic Adenocarcinoma of the Pancreas. 2016.